Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Astera Labs (ALAB) EBT (2023 - 2025)

Historic EBT for Astera Labs (ALAB) over the last 3 years, with Q3 2025 value amounting to $66.9 million.

  • Astera Labs' EBT rose 321656.75% to $66.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $149.9 million, marking a year-over-year increase of 28333.21%. This contributed to the annual value of -$81.8 million for FY2024, which is 25636.22% down from last year.
  • Per Astera Labs' latest filing, its EBT stood at $66.9 million for Q3 2025, which was up 321656.75% from $50.7 million recorded in Q2 2025.
  • Over the past 5 years, Astera Labs' EBT peaked at $66.9 million during Q3 2025, and registered a low of -$80.4 million during Q1 2024.
  • For the 3-year period, Astera Labs' EBT averaged around $3.1 million, with its median value being $2.0 million (2024).
  • As far as peak fluctuations go, Astera Labs' EBT plummeted by 36398.36% in 2024, and later skyrocketed by 321656.75% in 2025.
  • Astera Labs' EBT (Quarter) stood at $10.7 million in 2023, then rose by 0.07% to $10.7 million in 2024, then surged by 524.76% to $66.9 million in 2025.
  • Its last three reported values are $66.9 million in Q3 2025, $50.7 million for Q2 2025, and $21.7 million during Q1 2025.